1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Predictive Presymptomatic Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Molecular Testing 1.2.3 Cytogenic Testing 1.2.4 Biochemical Testing 1.3 Market by Application 1.3.1 Global Predictive Presymptomatic Testing Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Breast and Ovarian Cancer 1.3.3 Colorectal Cancer 1.3.4 Alzheimer's Disease 1.3.5 Multiple Endocrine Neoplasia Type 2 1.3.6 Haemochromatosis 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Predictive Presymptomatic Testing Market Perspective (2016-2027) 2.2 Predictive Presymptomatic Testing Growth Trends by Regions 2.2.1 Predictive Presymptomatic Testing Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Predictive Presymptomatic Testing Historic Market Share by Regions (2016-2021) 2.2.3 Predictive Presymptomatic Testing Forecasted Market Size by Regions (2022-2027) 2.3 Predictive Presymptomatic Testing Industry Dynamic 2.3.1 Predictive Presymptomatic Testing Market Trends 2.3.2 Predictive Presymptomatic Testing Market Drivers 2.3.3 Predictive Presymptomatic Testing Market Challenges 2.3.4 Predictive Presymptomatic Testing Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Predictive Presymptomatic Testing Players by Revenue 3.1.1 Global Top Predictive Presymptomatic Testing Players by Revenue (2016-2021) 3.1.2 Global Predictive Presymptomatic Testing Revenue Market Share by Players (2016-2021) 3.2 Global Predictive Presymptomatic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Predictive Presymptomatic Testing Revenue 3.4 Global Predictive Presymptomatic Testing Market Concentration Ratio 3.4.1 Global Predictive Presymptomatic Testing Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Predictive Presymptomatic Testing Revenue in 2020 3.5 Predictive Presymptomatic Testing Key Players Head office and Area Served 3.6 Key Players Predictive Presymptomatic Testing Product Solution and Service 3.7 Date of Enter into Predictive Presymptomatic Testing Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Predictive Presymptomatic Testing Breakdown Data by Type 4.1 Global Predictive Presymptomatic Testing Historic Market Size by Type (2016-2021) 4.2 Global Predictive Presymptomatic Testing Forecasted Market Size by Type (2022-2027) 5 Predictive Presymptomatic Testing Breakdown Data by Application 5.1 Global Predictive Presymptomatic Testing Historic Market Size by Application (2016-2021) 5.2 Global Predictive Presymptomatic Testing Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Predictive Presymptomatic Testing Market Size (2016-2027) 6.2 North America Predictive Presymptomatic Testing Market Size by Type 6.2.1 North America Predictive Presymptomatic Testing Market Size by Type (2016-2021) 6.2.2 North America Predictive Presymptomatic Testing Market Size by Type (2022-2027) 6.2.3 North America Predictive Presymptomatic Testing Market Size by Type (2016-2027) 6.3 North America Predictive Presymptomatic Testing Market Size by Application 6.3.1 North America Predictive Presymptomatic Testing Market Size by Application (2016-2021) 6.3.2 North America Predictive Presymptomatic Testing Market Size by Application (2022-2027) 6.3.3 North America Predictive Presymptomatic Testing Market Size by Application (2016-2027) 6.4 North America Predictive Presymptomatic Testing Market Size by Country 6.4.1 North America Predictive Presymptomatic Testing Market Size by Country (2016-2021) 6.4.2 North America Predictive Presymptomatic Testing Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Predictive Presymptomatic Testing Market Size (2016-2027) 7.2 Europe Predictive Presymptomatic Testing Market Size by Type 7.2.1 Europe Predictive Presymptomatic Testing Market Size by Type (2016-2021) 7.2.2 Europe Predictive Presymptomatic Testing Market Size by Type (2022-2027) 7.2.3 Europe Predictive Presymptomatic Testing Market Size by Type (2016-2027) 7.3 Europe Predictive Presymptomatic Testing Market Size by Application 7.3.1 Europe Predictive Presymptomatic Testing Market Size by Application (2016-2021) 7.3.2 Europe Predictive Presymptomatic Testing Market Size by Application (2022-2027) 7.3.3 Europe Predictive Presymptomatic Testing Market Size by Application (2016-2027) 7.4 Europe Predictive Presymptomatic Testing Market Size by Country 7.4.1 Europe Predictive Presymptomatic Testing Market Size by Country (2016-2021) 7.4.2 Europe Predictive Presymptomatic Testing Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Predictive Presymptomatic Testing Market Size (2016-2027) 8.2 Asia-Pacific Predictive Presymptomatic Testing Market Size by Type 8.2.1 Asia-Pacific Predictive Presymptomatic Testing Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Predictive Presymptomatic Testing Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Predictive Presymptomatic Testing Market Size by Type (2016-2027) 8.3 Asia-Pacific Predictive Presymptomatic Testing Market Size by Application 8.3.1 Asia-Pacific Predictive Presymptomatic Testing Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Predictive Presymptomatic Testing Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Predictive Presymptomatic Testing Market Size by Application (2016-2027) 8.4 Asia-Pacific Predictive Presymptomatic Testing Market Size by Region 8.4.1 Asia-Pacific Predictive Presymptomatic Testing Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Predictive Presymptomatic Testing Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Predictive Presymptomatic Testing Market Size (2016-2027) 9.2 Latin America Predictive Presymptomatic Testing Market Size by Type 9.2.1 Latin America Predictive Presymptomatic Testing Market Size by Type (2016-2021) 9.2.2 Latin America Predictive Presymptomatic Testing Market Size by Type (2022-2027) 9.2.3 Latin America Predictive Presymptomatic Testing Market Size by Type (2016-2027) 9.3 Latin America Predictive Presymptomatic Testing Market Size by Application 9.3.1 Latin America Predictive Presymptomatic Testing Market Size by Application (2016-2021) 9.3.2 Latin America Predictive Presymptomatic Testing Market Size by Application (2022-2027) 9.3.3 Latin America Predictive Presymptomatic Testing Market Size by Application (2016-2027) 9.4 Latin America Predictive Presymptomatic Testing Market Size by Country 9.4.1 Latin America Predictive Presymptomatic Testing Market Size by Country (2016-2021) 9.4.2 Latin America Predictive Presymptomatic Testing Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Predictive Presymptomatic Testing Market Size (2016-2027) 10.2 Middle East & Africa Predictive Presymptomatic Testing Market Size by Type 10.2.1 Middle East & Africa Predictive Presymptomatic Testing Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Predictive Presymptomatic Testing Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Predictive Presymptomatic Testing Market Size by Type (2016-2027) 10.3 Middle East & Africa Predictive Presymptomatic Testing Market Size by Application 10.3.1 Middle East & Africa Predictive Presymptomatic Testing Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Predictive Presymptomatic Testing Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Predictive Presymptomatic Testing Market Size by Application (2016-2027) 10.4 Middle East & Africa Predictive Presymptomatic Testing Market Size by Country 10.4.1 Middle East & Africa Predictive Presymptomatic Testing Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Predictive Presymptomatic Testing Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 23andMe, Inc. 11.1.1 23andMe, Inc. Company Details 11.1.2 23andMe, Inc. Business Overview 11.1.3 23andMe, Inc. Predictive Presymptomatic Testing Introduction 11.1.4 23andMe, Inc. Revenue in Predictive Presymptomatic Testing Business (2016-2021) 11.1.5 23andMe, Inc. Recent Development 11.2 Abbott Laboratories 11.2.1 Abbott Laboratories Company Details 11.2.2 Abbott Laboratories Business Overview 11.2.3 Abbott Laboratories Predictive Presymptomatic Testing Introduction 11.2.4 Abbott Laboratories Revenue in Predictive Presymptomatic Testing Business (2016-2021) 11.2.5 Abbott Laboratories Recent Development 11.3 Bayer HealthCare AG 11.3.1 Bayer HealthCare AG Company Details 11.3.2 Bayer HealthCare AG Business Overview 11.3.3 Bayer HealthCare AG Predictive Presymptomatic Testing Introduction 11.3.4 Bayer HealthCare AG Revenue in Predictive Presymptomatic Testing Business (2016-2021) 11.3.5 Bayer HealthCare AG Recent Development 11.4 Biocartis SA 11.4.1 Biocartis SA Company Details 11.4.2 Biocartis SA Business Overview 11.4.3 Biocartis SA Predictive Presymptomatic Testing Introduction 11.4.4 Biocartis SA Revenue in Predictive Presymptomatic Testing Business (2016-2021) 11.4.5 Biocartis SA Recent Development 11.5 BioHelix Corporation 11.5.1 BioHelix Corporation Company Details 11.5.2 BioHelix Corporation Business Overview 11.5.3 BioHelix Corporation Predictive Presymptomatic Testing Introduction 11.5.4 BioHelix Corporation Revenue in Predictive Presymptomatic Testing Business (2016-2021) 11.5.5 BioHelix Corporation Recent Development 11.6 bioMerieux S.A. 11.6.1 bioMerieux S.A. Company Details 11.6.2 bioMerieux S.A. Business Overview 11.6.3 bioMerieux S.A. Predictive Presymptomatic Testing Introduction 11.6.4 bioMerieux S.A. Revenue in Predictive Presymptomatic Testing Business (2016-2021) 11.6.5 bioMerieux S.A. Recent Development 11.7 Celera Corporation (Quest Diagnostics) 11.7.1 Celera Corporation (Quest Diagnostics) Company Details 11.7.2 Celera Corporation (Quest Diagnostics) Business Overview 11.7.3 Celera Corporation (Quest Diagnostics) Predictive Presymptomatic Testing Introduction 11.7.4 Celera Corporation (Quest Diagnostics) Revenue in Predictive Presymptomatic Testing Business (2016-2021) 11.7.5 Celera Corporation (Quest Diagnostics) Recent Development 11.8 Cepheid (Danaher) 11.8.1 Cepheid (Danaher) Company Details 11.8.2 Cepheid (Danaher) Business Overview 11.8.3 Cepheid (Danaher) Predictive Presymptomatic Testing Introduction 11.8.4 Cepheid (Danaher) Revenue in Predictive Presymptomatic Testing Business (2016-2021) 11.8.5 Cepheid (Danaher) Recent Development 11.9 Daan Diagnostics Ltd. 11.9.1 Daan Diagnostics Ltd. Company Details 11.9.2 Daan Diagnostics Ltd. Business Overview 11.9.3 Daan Diagnostics Ltd. Predictive Presymptomatic Testing Introduction 11.9.4 Daan Diagnostics Ltd. Revenue in Predictive Presymptomatic Testing Business (2016-2021) 11.9.5 Daan Diagnostics Ltd. Recent Development 11.10 EKF Diagnostics Holdings plc 11.10.1 EKF Diagnostics Holdings plc Company Details 11.10.2 EKF Diagnostics Holdings plc Business Overview 11.10.3 EKF Diagnostics Holdings plc Predictive Presymptomatic Testing Introduction 11.10.4 EKF Diagnostics Holdings plc Revenue in Predictive Presymptomatic Testing Business (2016-2021) 11.10.5 EKF Diagnostics Holdings plc Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Predictive Presymptomatic Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Molecular Testing Table 3. Key Players of Cytogenic Testing Table 4. Key Players of Biochemical Testing Table 5. Global Predictive Presymptomatic Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Predictive Presymptomatic Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Predictive Presymptomatic Testing Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Predictive Presymptomatic Testing Market Share by Regions (2016-2021) Table 9. Global Predictive Presymptomatic Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Predictive Presymptomatic Testing Market Share by Regions (2022-2027) Table 11. Predictive Presymptomatic Testing Market Trends Table 12. Predictive Presymptomatic Testing Market Drivers Table 13. Predictive Presymptomatic Testing Market Challenges Table 14. Predictive Presymptomatic Testing Market Restraints Table 15. Global Predictive Presymptomatic Testing Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Predictive Presymptomatic Testing Market Share by Players (2016-2021) Table 17. Global Top Predictive Presymptomatic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Predictive Presymptomatic Testing as of 2020) Table 18. Ranking of Global Top Predictive Presymptomatic Testing Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Predictive Presymptomatic Testing Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Predictive Presymptomatic Testing Product Solution and Service Table 22. Date of Enter into Predictive Presymptomatic Testing Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Predictive Presymptomatic Testing Market Size by Type (2016-2021) (US$ Million) Table 25. Global Predictive Presymptomatic Testing Revenue Market Share by Type (2016-2021) Table 26. Global Predictive Presymptomatic Testing Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Predictive Presymptomatic Testing Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Predictive Presymptomatic Testing Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Predictive Presymptomatic Testing Revenue Market Share by Application (2016-2021) Table 30. Global Predictive Presymptomatic Testing Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Predictive Presymptomatic Testing Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Predictive Presymptomatic Testing Market Size by Type (2016-2021) (US$ Million) Table 33. North America Predictive Presymptomatic Testing Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Predictive Presymptomatic Testing Market Size by Application (2016-2021) (US$ Million) Table 35. North America Predictive Presymptomatic Testing Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Predictive Presymptomatic Testing Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Predictive Presymptomatic Testing Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Predictive Presymptomatic Testing Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Predictive Presymptomatic Testing Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Predictive Presymptomatic Testing Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Predictive Presymptomatic Testing Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Predictive Presymptomatic Testing Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Predictive Presymptomatic Testing Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Predictive Presymptomatic Testing Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Predictive Presymptomatic Testing Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Predictive Presymptomatic Testing Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Predictive Presymptomatic Testing Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Predictive Presymptomatic Testing Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Predictive Presymptomatic Testing Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Predictive Presymptomatic Testing Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Predictive Presymptomatic Testing Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Predictive Presymptomatic Testing Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Predictive Presymptomatic Testing Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Predictive Presymptomatic Testing Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Predictive Presymptomatic Testing Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Predictive Presymptomatic Testing Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Predictive Presymptomatic Testing Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Predictive Presymptomatic Testing Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Predictive Presymptomatic Testing Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Predictive Presymptomatic Testing Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Predictive Presymptomatic Testing Market Size by Country (2022-2027) & (US$ Million) Table 62. 23andMe, Inc. Company Details Table 63. 23andMe, Inc. Business Overview Table 64. 23andMe, Inc. Predictive Presymptomatic Testing Product Table 65. 23andMe, Inc. Revenue in Predictive Presymptomatic Testing Business (2016-2021) & (US$ Million) Table 66. 23andMe, Inc. Recent Development Table 67. Abbott Laboratories Company Details Table 68. Abbott Laboratories Business Overview Table 69. Abbott Laboratories Predictive Presymptomatic Testing Product Table 70. Abbott Laboratories Revenue in Predictive Presymptomatic Testing Business (2016-2021) & (US$ Million) Table 71. Abbott Laboratories Recent Development Table 72. Bayer HealthCare AG Company Details Table 73. Bayer HealthCare AG Business Overview Table 74. Bayer HealthCare AG Predictive Presymptomatic Testing Product Table 75. Bayer HealthCare AG Revenue in Predictive Presymptomatic Testing Business (2016-2021) & (US$ Million) Table 76. Bayer HealthCare AG Recent Development Table 77. Biocartis SA Company Details Table 78. Biocartis SA Business Overview Table 79. Biocartis SA Predictive Presymptomatic Testing Product Table 80. Biocartis SA Revenue in Predictive Presymptomatic Testing Business (2016-2021) & (US$ Million) Table 81. Biocartis SA Recent Development Table 82. BioHelix Corporation Company Details Table 83. BioHelix Corporation Business Overview Table 84. BioHelix Corporation Predictive Presymptomatic Testing Product Table 85. BioHelix Corporation Revenue in Predictive Presymptomatic Testing Business (2016-2021) & (US$ Million) Table 86. BioHelix Corporation Recent Development Table 87. bioMerieux S.A. Company Details Table 88. bioMerieux S.A. Business Overview Table 89. bioMerieux S.A. Predictive Presymptomatic Testing Product Table 90. bioMerieux S.A. Revenue in Predictive Presymptomatic Testing Business (2016-2021) & (US$ Million) Table 91. bioMerieux S.A. Recent Development Table 92. Celera Corporation (Quest Diagnostics) Company Details Table 93. Celera Corporation (Quest Diagnostics) Business Overview Table 94. Celera Corporation (Quest Diagnostics) Predictive Presymptomatic Testing Product Table 95. Celera Corporation (Quest Diagnostics) Revenue in Predictive Presymptomatic Testing Business (2016-2021) & (US$ Million) Table 96. Celera Corporation (Quest Diagnostics) Recent Development Table 97. Cepheid (Danaher) Company Details Table 98. Cepheid (Danaher) Business Overview Table 99. Cepheid (Danaher) Revenue in Predictive Presymptomatic Testing Business (2016-2021) & (US$ Million) Table 100. Cepheid (Danaher) Recent Development Table 101. Daan Diagnostics Ltd. Company Details Table 102. Daan Diagnostics Ltd. Business Overview Table 103. Daan Diagnostics Ltd. Predictive Presymptomatic Testing Product Table 104. Daan Diagnostics Ltd. Revenue in Predictive Presymptomatic Testing Business (2016-2021) & (US$ Million) Table 105. Daan Diagnostics Ltd. Recent Development Table 106. EKF Diagnostics Holdings plc Company Details Table 107. EKF Diagnostics Holdings plc Business Overview Table 108. EKF Diagnostics Holdings plc Predictive Presymptomatic Testing Product Table 109. EKF Diagnostics Holdings plc Revenue in Predictive Presymptomatic Testing Business (2016-2021) & (US$ Million) Table 110. EKF Diagnostics Holdings plc Recent Development Table 111. Research Programs/Design for This Report Table 112. Key Data Information from Secondary Sources Table 113. Key Data Information from Primary Sources List of Figures Figure 1. Global Predictive Presymptomatic Testing Market Share by Type: 2020 VS 2027 Figure 2. Molecular Testing Features Figure 3. Cytogenic Testing Features Figure 4. Biochemical Testing Features Figure 5. Global Predictive Presymptomatic Testing Market Share by Application: 2020 VS 2027 Figure 6. Breast and Ovarian Cancer Case Studies Figure 7. Colorectal Cancer Case Studies Figure 8. Alzheimer's Disease Case Studies Figure 9. Multiple Endocrine Neoplasia Type 2 Case Studies Figure 10. Haemochromatosis Case Studies Figure 11. Predictive Presymptomatic Testing Report Years Considered Figure 12. Global Predictive Presymptomatic Testing Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 13. Global Predictive Presymptomatic Testing Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Predictive Presymptomatic Testing Market Share by Regions: 2020 VS 2027 Figure 15. Global Predictive Presymptomatic Testing Market Share by Regions (2022-2027) Figure 16. Global Predictive Presymptomatic Testing Market Share by Players in 2020 Figure 17. Global Top Predictive Presymptomatic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Predictive Presymptomatic Testing as of 2020 Figure 18. The Top 10 and 5 Players Market Share by Predictive Presymptomatic Testing Revenue in 2020 Figure 19. Global Predictive Presymptomatic Testing Revenue Market Share by Type (2016-2021) Figure 20. Global Predictive Presymptomatic Testing Revenue Market Share by Type (2022-2027) Figure 21. North America Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. North America Predictive Presymptomatic Testing Market Share by Type (2016-2027) Figure 23. North America Predictive Presymptomatic Testing Market Share by Application (2016-2027) Figure 24. North America Predictive Presymptomatic Testing Market Share by Country (2016-2027) Figure 25. United States Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Canada Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Predictive Presymptomatic Testing Market Share by Type (2016-2027) Figure 29. Europe Predictive Presymptomatic Testing Market Share by Application (2016-2027) Figure 30. Europe Predictive Presymptomatic Testing Market Share by Country (2016-2027) Figure 31. Germany Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. France Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. U.K. Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Italy Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Russia Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Nordic Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Predictive Presymptomatic Testing Market Share by Type (2016-2027) Figure 39. Asia-Pacific Predictive Presymptomatic Testing Market Share by Application (2016-2027) Figure 40. Asia-Pacific Predictive Presymptomatic Testing Market Share by Region (2016-2027) Figure 41. China Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Japan Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. South Korea Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Southeast Asia Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. India Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Australia Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Predictive Presymptomatic Testing Market Share by Type (2016-2027) Figure 49. Latin America Predictive Presymptomatic Testing Market Share by Application (2016-2027) Figure 50. Latin America Predictive Presymptomatic Testing Market Share by Country (2016-2027) Figure 51. Mexico Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Brazil Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Predictive Presymptomatic Testing Market Share by Type (2016-2027) Figure 55. Middle East & Africa Predictive Presymptomatic Testing Market Share by Application (2016-2027) Figure 56. Middle East & Africa Predictive Presymptomatic Testing Market Share by Country (2016-2027) Figure 57. Turkey Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Saudi Arabia Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. UAE Predictive Presymptomatic Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. 23andMe, Inc. Revenue Growth Rate in Predictive Presymptomatic Testing Business (2016-2021) Figure 61. Abbott Laboratories Revenue Growth Rate in Predictive Presymptomatic Testing Business (2016-2021) Figure 62. Bayer HealthCare AG Revenue Growth Rate in Predictive Presymptomatic Testing Business (2016-2021) Figure 63. Biocartis SA Revenue Growth Rate in Predictive Presymptomatic Testing Business (2016-2021) Figure 64. BioHelix Corporation Revenue Growth Rate in Predictive Presymptomatic Testing Business (2016-2021) Figure 65. bioMerieux S.A. Revenue Growth Rate in Predictive Presymptomatic Testing Business (2016-2021) Figure 66. Celera Corporation (Quest Diagnostics) Revenue Growth Rate in Predictive Presymptomatic Testing Business (2016-2021) Figure 67. Cepheid (Danaher) Revenue Growth Rate in Predictive Presymptomatic Testing Business (2016-2021) Figure 68. Daan Diagnostics Ltd. Revenue Growth Rate in Predictive Presymptomatic Testing Business (2016-2021) Figure 69. EKF Diagnostics Holdings plc Revenue Growth Rate in Predictive Presymptomatic Testing Business (2016-2021) Figure 70. Bottom-up and Top-down Approaches for This Report Figure 71. Data Triangulation Figure 72. Key Executives Interviewed

23andMe, Inc. Abbott Laboratories Bayer HealthCare AG Biocartis SA BioHelix Corporation bioMerieux S.A. Celera Corporation (Quest Diagnostics) Cepheid (Danaher) Daan Diagnostics Ltd. EKF Diagnostics Holdings plc